Compare Citigroup Inc. (C) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citigroup Inc. vs Novavax Inc — how do they compare? Citigroup Inc. trades at $135.93 (market cap $227.75B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Citigroup Inc. is far larger — about 173.9× Novavax Inc's market cap, and Citigroup Inc. pays a 1.97% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| C | NVAX | |
|---|---|---|
Market Cap | $227.75B | $1.31B |
Sector | Financials | Health |
52-Week High | $145.67 | $11.19 |
52-Week Low | $92.59 | $6.22 |
Dividend Yield | 1.97% | — |
Enterprise Value | — | $889.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
